Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.
- DOI
- 10.1186/s40425-018-0461-4
- Published
- 2018 Dec 5
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40425-018-0461-4,
title = {Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.},
author = {Abu-Sbeih H and Ali FS and Alsaadi D and Jennings J and Luo W and Gong Z and Richards DM and Charabaty A and Wang Y},
year = {2018},
journal = {Journal for immunotherapy of cancer},
doi = {10.1186/s40425-018-0461-4},
url = {https://doi.org/10.1186/s40425-018-0461-4}
}RIS
TY - JOUR TI - Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study. AU - Abu-Sbeih H AU - Ali FS AU - Alsaadi D AU - Jennings J AU - Luo W AU - Gong Z AU - Richards DM AU - Charabaty A AU - Wang Y PY - 2018 JO - Journal for immunotherapy of cancer DO - 10.1186/s40425-018-0461-4 UR - https://doi.org/10.1186/s40425-018-0461-4 ER -
APA
H, A., FS, A., D, A., J, J., W, L., Z, G., DM, R., A, C., & Y, W. (2018). Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor-induced colitis: a multi-center study.. Journal for immunotherapy of cancer. https://doi.org/10.1186/s40425-018-0461-4
Source records
- pubmed · retrieved 2026-11-10T13:45:48.517Z